AGGREGATION STATE AND NEUROTOXIC PROPERTIES OF ALZHEIMER BETA-AMYLOID PEPTIDE

被引:181
|
作者
HOWLETT, DR
JENNINGS, KH
LEE, DC
CLARK, MSG
BROWN, F
WETZEL, R
WOOD, SJ
CAMILLERI, P
ROBERTS, GW
机构
[1] SMITHKLINE BEECHAM PHARMACEUT,WELWYN GARDEN CIT,HERTS,ENGLAND
[2] SMITHKLINE BEECHAM PHARMACEUT,KING OF PRUSSIA,PA 19406
来源
NEURODEGENERATION | 1995年 / 4卷 / 01期
关键词
ALZHEIMERS DISEASE; BETA-AMYLOID PROTEIN; ELECTRON MICROSCOPY; FIBRIL FORMATION; NEUROTOXICITY;
D O I
10.1006/neur.1995.0003
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The behaviour of synthetic batches of beta-amyloid (beta A) 1-40 peptide in solution has been studied. The effects of beta A1-40 on a PC12 cell toxicity assay was dependent upon the time of preincubation of an aqueous solution of the peptide before application to the cells. Fibrillization of the beta A1-40, quantitatively assessed by the binding of Congo red to amyloid fibrils, also increased in a time dependent manner over the 168 h incubation period studied. The degree of Congo red binding, in the absence of any preincubation, differed between two synthetically distinct batches of the peptide. The rate of development of fibril formation during subsequent incubation also differed between the two batches and appeared to parallel the effects on cell viability. Infra-red spectroscopic analysis revealed beta-sheet formation for both batches and other more subtle conformational differences between the peptides. Electron microscope examination of the batches of beta A1-40 confirmed the difference in occurrence and development of fibrils. At high magnification, fibrils of both batches exhibited a helical structure. The results suggest that the development of neurotoxicity of beta A1-40 is related to the fibrillar state of the peptide.
引用
收藏
页码:23 / 32
页数:10
相关论文
共 50 条
  • [1] Aggregation State and Neurotoxic Properties of Alzheimer β-Amyloid Peptide
    Mohamed, Amany
    Cortez, Leonardo
    de Chaves, Elena Posse
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2011, 12 (03) : 235 - 257
  • [2] Inhibitory effect of monoclonal antibodies on Alzheimer's beta-amyloid peptide aggregation
    Hanan, E
    Solomon, B
    AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION, 1996, 3 (02): : 130 - 133
  • [3] Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer beta-amyloid peptide
    Solomon, B
    Koppel, R
    Hanan, E
    Katzav, T
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (01) : 452 - 455
  • [4] KINETICS OF AGGREGATION OF SYNTHETIC BETA-AMYLOID PEPTIDE
    TOMSKI, SJ
    MURPHY, RM
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1992, 294 (02) : 630 - 638
  • [5] DYNAMIC CHANGES IN AGGREGATION STATE OF AMYLOID-BETA PEPTIDE (A-BETA) CORRELATE WITH ALTERED NEUROTOXIC PROPERTIES
    MAY, PC
    FUSON, KS
    BOGGS, LN
    NEUROBIOLOGY OF AGING, 1994, 15 : S18 - S18
  • [6] ACTIVATION OF MACROPHAGES BY ALZHEIMER BETA-AMYLOID PEPTIDE
    KLEGERIS, A
    WALKER, DG
    MCGEER, PL
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 199 (02) : 984 - 991
  • [7] The neuroprotective peptide NAP inhibits the aggregation of the beta-amyloid peptide
    Ashur-Fabian, O
    Segal-Ruder, Y
    Skutelsky, E
    Brenneman, DE
    Steingart, RA
    Giladi, E
    Gozes, I
    PEPTIDES, 2003, 24 (09) : 1413 - 1423
  • [8] Interactions of Alzheimer beta-amyloid peptide with phospholipid membranes
    McLaurin, J
    Chakrabartty, A
    JOURNAL OF NEUROCHEMISTRY, 1996, 66 : S9 - S9
  • [9] Fusogenic properties of the C-terminal domain of the Alzheimer beta-amyloid peptide
    Pillot, T
    Goethals, M
    Vanloo, B
    Talussot, C
    Brasseur, R
    Vandekerckhove, J
    Rosseneu, M
    Lins, L
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (46) : 28757 - 28765
  • [10] Why is the amyloid beta peptide of Alzheimer's disease neurotoxic?
    Rauk, Arvi
    DALTON TRANSACTIONS, 2008, (10) : 1273 - 1282